Table 3

Meta-analysis results for all outcomes pooled across different tendinopathy locations

Tendinopathy
Location
Small
(95%CrI)
Medium
(95%CrI)
Large
(95%CrI)
Study
VPC
(75%CrI)
Outcome VPC
(75%CrI)
Measurement VPC
(75%CrI)
All0.34
(0.31 to 0.37)
0.73
(0.70 to 0.77)
1.21
(1.17 to 1.27)
0.73
(0.68 to 0.77)
0.27
(0.22 to 0.32)
0.01
(0.00 to 0.02)
RCRSP0.38
(0.34 to 0.42)
0.74
(0.70 to 0.78)
1.18
(1.13 to 1.24)
0.55
(0.48 to 0.62)
0.45
(0.37 to 0.52)
0.01
(0.00 to 0.02)
Achilles0.32
(0.25 to 0.38)
0.70
(0.62 to 0.78)
1.22
(1.10 to 1.34)
0.71
(0.59 to 0.81)
0.27
(0.18 to 0.39)
0.01
(0.00 to 0.03)
Elbow0.28
(0.17 to 0.39)
0.82
(0.72 to 0.92)
1.49
(1.31 to 1.68)
0.90
(0.84 to 0.94)
0.10
(0.06 to 0.15)
0.01
(0.00 to 0.02)
Patellar0.33
(0.19 to 0.46)
0.69
(0.55 to 0.84)
1.21
(1.00 to 1.43)
0.46
(0.13 to 0.69)
0.52
(0.29 to 0.85)
0.01
(0.00 to 0.05)
  • Small: 0.25 quantile; medium: 0.5 quantile; large: 0.75 quantile.

  • CrI, credible interval; RCRSP, rotator cuff related shoulder pain; VPC, variance partition coefficient.